IL-SEVAN-MULTI-SITE
26.7.2022 15:02:04 CEST | Business Wire | Press release
Sevan Multi-Site Solutions, Inc. (Sevan ) is officially certified as a veteran owned business.
Sevan, a global leader in innovative program management for clients with multiple sites, is certified as a Veteran-Owned Business by National Veteran Business Development Council (NVBDC) and a Certified Veteran’s Business Enterprise™ (VBE) via the National Veteran-Owned Business Association (NaVOBA).
Sevan is honored to partner with both NVBDC and NaVOBA, and very excited about this milestone for the organization.
“Being validated as a mid-sized Veteran Owned Business was part of our three-year strategic plan,” said Jim Evans, Founder and CEO of Sevan. “Since different clients partner with either NVBDC or NaVOBA to maximize their diverse spend goals, it’s key to be certified by both. Now that we are—this will broaden and deepen our network of clients and partners.”
Partnerships with NVBDC and NaVOBA create corporate contracting opportunities for veteran and service-disabled veteran businesses via certification, advocacy, outreach, recognition and education.
“These certifications will make us even more unique and competitive to win future work— and strengthen Sevan’s footprint in the multi-site space,” Evans said. “We are also confident these stamps of approval will provide us the opportunity to recruit talented and well-equipped people transitioning out of the military and into civilian work.”
The certification process included a comprehensive list of business requirements and criteria, along with a rigorous examination and verification process.
“What a fun and exciting time to be at Sevan—for our entire team,” said David Hendrix, Chief Commercial Officer. “Now that Sevan qualifies as a diverse supplier, we look even more forward to partnering with current and new clients to contribute to our nation’s diverse spend initiatives.”
In 2022, Sevan was recognized as an Employee-Rated Great Place to Work® for the 9th consecutive year. Also in 2022, Sevan ranked No. 36 on Engineering News-Record (ENR)’s Top 50 Program Management Firms and No. 57 on ENR’s Top 100 Construction Management-for-Fee Firms. In 2021, Sevan ranked on the Inc. 5000 list of the nation’s fastest-growing private companies for the 4th consecutive year and earned the Gold HIRE Vets Medallion Award. In 2020, Sevan ranked No. 124 on the Financial Times FT 1000 list of America’s Fastest-Growing Companies. Visit our website to learn more about Sevan.
About Sevan
Sevan is an innovative global leader in design, program management, construction services and data analytics for organizations with multiple sites. Sevan puts capital to work—creating speed and scale—via dramatically enhanced efficiencies and accelerated schedules for high-quality program rollouts to maximize ROI. We partner with some of the world’s biggest brands and serve the unique needs of clients in the restaurant, retail and government spaces and create unlimited value. Sevan’s team spans across four countries and 40 states. As an extension of your team, our in-house experts manage capital improvement initiatives through every step of a program’s lifecycle.
Sevan helps iconic brands optimize their multi-site construction and facility programs in the United States and internationally. Sevan is headquartered near Chicago in Downers Grove, Illinois and has an international office in London.
Sevan strategically guides worldwide brands—including 7-Eleven, AAFES, Albertsons, Amtrak, BP, Carbon Health, Chipotle, Corvias, DaVita, Department of Veteran Affairs, Focus Brands, HCA Healthcare, HEB, Inspire Brands, Jiffy Lube, Kroger, Luxottica, McDonald’s, Motor Fuel Group, Office Depot, Popeyes, QDOBA, Starbucks, Sunoco, Walgreens Boots Alliance, Walmart, WOW Carwash and Yum! Brands—through their entire turnkey program lifecycle. Sevan rolls out multi-site initiatives efficiently, predictably and transparently. Applying breakthrough technology solutions, Sevan optimizes construction of new builds, rebuilds, remodels and renovations. Sevan has licensed architects in 49 states as well as D.C., Canadian provinces, Guam and the Northern Mariana Islands. Sevan has professional engineers on staff and general contractor licenses in more than 25 states. Since Sevan’s inception in 2011, the team has refreshed more than 25,000 retail stores, 17,000 restaurants and 32,000 healthcare sites. The team has also completed more than 32,000 surveys, totaling more than 1 billion square feet.
Sevan recently officially became a Veteran Owned Business via the National Veteran Business Development Council (NVBDC) and earned the exclusive designation as a Certified Veteran’s Business Enterprise™ (VBE) from the National Veteran-Owned Business Association (NaVOBA). Sevan Elevate, a program that reinforces and continuously improves safety and sustainability across the company, is designed to impactfully deliver excellence to Sevan’s people and clients.
To learn more about Sevan’s offerings, visit www.sevansolutions.com .
For more information, please contact Hafsa Mahmood by calling 708.723.3849 or via e-mail at hafsa.mahmood@sevansolutions.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220726005494/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press release
New platform brings real-time electrical control to coiled tubing intervention, enabling greater precision, visibility and efficiency across intervention operations SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased p
Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press release
By transforming authoritative legal content into structured legal intelligence, Wolters Kluwer gives AI the context and relationships needed to deliver deeper research and higher-quality results Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI c
Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press release
Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 09:01:00 CEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press release
Discovered by Takeda in Japan, ORZEYFUL has the Potential to Redefine Care Beyond Individual Symptom Management for Adults Living with Narcolepsy Type 1 (NT1) Landmark Phase 3 Studies Demonstrated Significant and Meaningful Improvements Across the Full Range of NT1 Symptoms Evaluated in Clinical Trials Compared to Placebo Milestone Marks Third Major Regulatory Approval Secured for ORZEYFUL Around the World Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
